Funding
Tokyo startup Time Traveler advances in 101 million dollar XPRIZE Healthspan
Time Traveler was selected as a Milestone 2 Awardee in the 101 million dollar XPRIZE Healthspan competition for its plant-based longevity approach.
News · Funding
News
What companies, regulators and the press said about aging biology this week, in our own words, with the source a tap away.
Yesterday
Wednesday 30 September
Funding
Immortal Dragons invests in patient-matched cell startup Renewal Bio
The $40 million longevity fund backed the Israeli regenerative medicine company to support its Stembroid platform for producing patient-matched cells through natural developmental programs.